Atlas Trials

Zyprexa® Relprevv™ Patient Care Program

Clinical trial NCT01088386 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT01088386
Sponsor
Eli Lilly and Company
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
Schizophrenia
Start date
2010-03-03
Primary completion
2026-06-01
Enrollment
4000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.